Helius Total Current Liabilities from 2010 to 2024

HSDT Stock  USD 4.82  0.16  3.21%   
Helius Medical Total Current Liabilities yearly trend continues to be comparatively stable with very little volatility. Total Current Liabilities will likely drop to about 1.8 M in 2024. Total Current Liabilities is the total amount of liabilities that Helius Medical Technologies is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2014-03-31
Previous Quarter
1.4 M
Current Value
1.9 M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many exotic indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
This module can also supplement various Helius Medical Technical models . Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Helius Medical Technologies over the last few years. Total Current Liabilities is an item on Helius Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Helius Medical Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Helius Medical's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Pretty Stable
   Total Current Liabilities   
       Timeline  

Helius Total Current Liabilities Regression Statistics

Arithmetic Mean3,970,801
Geometric Mean2,145,287
Coefficient Of Variation132.03
Mean Deviation3,633,813
Median1,988,000
Standard Deviation5,242,548
Sample Variance27.5T
Range17.4M
R-Value0.15
Mean Square Error28.9T
R-Squared0.02
Significance0.59
Slope175,617
Total Sum of Squares384.8T

Helius Total Current Liabilities History

20241.8 M
20231.9 M
2022M
20212.7 M
20202.4 M
20193.8 M
201818 M

About Helius Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Helius Medical income statement, its balance sheet, and the statement of cash flows. Helius Medical investors use historical funamental indicators, such as Helius Medical's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may use each financial statement separately, they are all related. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Helius Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Helius Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Helius Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Liabilities1.9 M1.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Helius Medical Techn is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Helius Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Helius Medical Technologies Stock. Highlighted below are key reports to facilitate an investment decision about Helius Medical Technologies Stock:
Check out the analysis of Helius Medical Correlation against competitors.
Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Helius Stock analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.56)
Revenue Per Share
1.059
Quarterly Revenue Growth
(0.53)
Return On Assets
(0.61)
Return On Equity
(1.69)
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.